Minnelide is a water-soluble prodrug of triptolide, used in cancer therapy. It has shown effectiveness in preclinical models for various cancers, including pancreatic, liver, and gastric cancer, and is being investigated in clinical trials. It works by targeting cancer-promoting cells and pathways, including super enhancers and heat shock proteins. The directory classifies it as a clinical API with a semi-synthetic source/manufacturing origin. Other names for this substance include 14-O-Phosphonooxymethyltriptolide disodium salt and Triptolide Impurity 1. Its PubChem CID is 46203139.
Minnelide
| CAS No | 1254702-87-8 |
|---|---|
| Molecular Formula | C21H25Na2O10P |
| Molecular Weight | 514.40 g/mol |
| Synonyms | disodium;[(1S,2S,4S,5S,7S,8R,9R,11S,13S)-1-methyl-17-oxo-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-8-yl]oxymethyl phosphate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Minnelide is a water-soluble prodrug of triptolide, used in cancer therapy. It has shown effectiveness in preclinical models for various cancers, including pancreatic, liver, and gastric cancer, and is being investigated in clinical trials.
The listed CAS number is 1254702-87-8.
The listed molecular formula is C21H25Na2O10P.
The listed molecular weight is 514.40 g/mol.
disodium;[(1S,2S,4S,5S,7S,8R,9R,11S,13S)-1-methyl-17-oxo-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-8-yl]oxymethyl phosphate.
The source lists 14-O-Phosphonooxymethyltriptolide disodium salt and Triptolide Impurity 1.